ONEM Stock Overview
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.
1Life Healthcare Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$16.96|
|52 Week High||US$27.92|
|52 Week Low||US$5.94|
|1 Month Change||46.84%|
|3 Month Change||152.01%|
|1 Year Change||-40.82%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-23.15%|
Recent News & Updates
|ONEM||US Healthcare||US Market|
Return vs Industry: ONEM underperformed the US Healthcare industry which returned 12.6% over the past year.
Return vs Market: ONEM underperformed the US Market which returned -12.9% over the past year.
|ONEM Average Weekly Movement||24.5%|
|Healthcare Industry Average Movement||9.6%|
|Market Average Movement||7.9%|
|10% most volatile stocks in US Market||17.2%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: ONEM is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 25% a week.
Volatility Over Time: ONEM's weekly volatility has increased from 16% to 25% over the past year.
About the Company
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.
1Life Healthcare Fundamentals Summary
|ONEM fundamental statistics|
Is ONEM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ONEM income statement (TTM)|
|Cost of Revenue||US$719.36m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.84|
|Net Profit Margin||-40.24%|
How did ONEM perform over the long term?See historical performance and comparison
Is ONEM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ONEM?
Other financial metrics that can be useful for relative valuation.
|What is ONEM's n/a Ratio?|
Price to Sales Ratio vs Peers
How does ONEM's PS Ratio compare to its peers?
|ONEM PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
AMN AMN Healthcare Services
OSH Oak Street Health
GH Guardant Health
AMEH Apollo Medical Holdings
ONEM 1Life Healthcare
Price-To-Sales vs Peers: ONEM is good value based on its Price-To-Sales Ratio (3.7x) compared to the peer average (5.2x).
Price to Earnings Ratio vs Industry
How does ONEM's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Sales vs Industry: ONEM is expensive based on its Price-To-Sales Ratio (3.7x) compared to the US Healthcare industry average (1.5x)
Price to Sales Ratio vs Fair Ratio
What is ONEM's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||3.7x|
|Fair PS Ratio||2.5x|
Price-To-Sales vs Fair Ratio: ONEM is expensive based on its Price-To-Sales Ratio (3.7x) compared to the estimated Fair Price-To-Sales Ratio (2.5x).
Share Price vs Fair Value
What is the Fair Price of ONEM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ONEM's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ONEM's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is 1Life Healthcare forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ONEM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ONEM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ONEM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ONEM's revenue (21.9% per year) is forecast to grow faster than the US market (8% per year).
High Growth Revenue: ONEM's revenue (21.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ONEM is forecast to be unprofitable in 3 years.
Discover growth companies
How has 1Life Healthcare performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ONEM is currently unprofitable.
Growing Profit Margin: ONEM is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ONEM is unprofitable, and losses have increased over the past 5 years at a rate of 54.7% per year.
Accelerating Growth: Unable to compare ONEM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ONEM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.7%).
Return on Equity
High ROE: ONEM has a negative Return on Equity (-22.08%), as it is currently unprofitable.
Discover strong past performing companies
How is 1Life Healthcare's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: ONEM's short term assets ($560.3M) exceed its short term liabilities ($216.5M).
Long Term Liabilities: ONEM's short term assets ($560.3M) do not cover its long term liabilities ($700.0M).
Debt to Equity History and Analysis
Debt Level: ONEM has more cash than its total debt.
Reducing Debt: Insufficient data to determine if ONEM's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ONEM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ONEM has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 43.4% each year.
Discover healthy companies
What is 1Life Healthcare current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ONEM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ONEM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ONEM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ONEM's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ONEM has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Amir Rubin (52 yo)
Mr. Amir Dan Rubin, MBA, has been the Chief Executive Officer and President at 1Life Healthcare, Inc. since August 2017 and has been its Chair, since September 2017. From January 2016 to August 2017, he se...
CEO Compensation Analysis
Compensation vs Market: Amir's total compensation ($USD1.79M) is below average for companies of similar size in the US market ($USD6.58M).
Compensation vs Earnings: Amir's compensation has been consistent with company performance over the past year.
Experienced Management: ONEM's management team is considered experienced (2.9 years average tenure).
Experienced Board: ONEM's board of directors are considered experienced (3.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 41.6%.
1Life Healthcare, Inc.'s employee growth, exchange listings and data sources
- Name: 1Life Healthcare, Inc.
- Ticker: ONEM
- Exchange: NasdaqGS
- Founded: 2002
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$3.310b
- Shares outstanding: 195.18m
- Website: https://www.onemedical.com
Number of Employees
- 1Life Healthcare, Inc.
- One Embarcadero Center
- Suite 1900
- San Francisco
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/07 00:00|
|End of Day Share Price||2022/08/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.